A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

Elizabeth M. Brunt, Christine G. Janney, Adrian M. Di Bisceglie et al. · The American Journal of Gastroenterology · 1999 · 3.8K citations

Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

Christi A Matteoni, Zobair M. Younossi, T GRAMLICH et al. · Gastroenterology · 1999 · 3.4K citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

Renata Belfort, Stephen A. Harrison, Kenneth Brown et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

Shivakumar Chitturi, Shehan Abeygunasekera, Geoffrey C. Farrell et al. · Hepatology · 2002 · 1.1K citations

Metabolic Disorder, Insulin Resistance Syndrome, Insulin Hypersecretion +23

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis

A J Wigg · Gut · 2001 · 830 citations · Full text